TEKLA CAPITAL MANAGEMENT LLC – Travere Therapeutics, Inc. Transaction History
TEKLA CAPITAL MANAGEMENT LLC portfolio value:
$6.10M
portfolio value
TEKLA CAPITAL MANAGEMENT LLC quarter portfolio value change:
+1.69%
quarter
Travere Therapeutics, Inc. 13F transactions
| Quarter | Transaction type | Change | Relative change | Absolute change | Change value | Avg. price | Shares |
|---|---|---|---|---|---|---|---|
| Q3 2022 | share | 0.00% | 0 shares | 102K | $24.64 | 247.67K | |
| Q2 2022 | share | 0.00% | 0 shares | -382K | $24.23 | 247.67K | |
| Q1 2022 | share | Increase | +16.35% | 34.80K shares | -224K | $25.77 | 247.67K |
| Q4 2021 | share | 0.00% | 0 shares | 1.44M | $30.31 | 212.86K | |
| Q3 2021 | share | 0.00% | 0 shares | 2.05M | $24.25 | 212.86K | |
| Q2 2021 | share | 0.00% | 0 shares | -2.20M | $14.59 | 212.86K | |
| Q1 2021 | share | Increase | 0.00% | 212.86K shares | 5.31M | $24.97 | 212.86K |